Sale!

FGFR3 Gene Hypochondroplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR3 Gene Hypochondroplasia Genetic Test is a specialized diagnostic tool designed to identify mutations in the FGFR3 gene, which are associated with hypochondroplasia, a form of short-limbed dwarfism. This condition is characterized by moderate short stature, short limbs, and broad, short hands and feet. It is caused by specific genetic mutations in the FGFR3 gene, which plays a crucial role in bone development and growth.

The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a sample of the patient’s DNA, the test can pinpoint mutations in the FGFR3 gene, providing crucial information for diagnosis, management, and treatment planning for individuals with hypochondroplasia. The cost of the test is 4400 AED, an investment in gaining valuable insights into the genetic basis of the condition, which can aid in making informed decisions about care and support.

This genetic test is particularly important for families with a history of hypochondroplasia or for individuals showing symptoms of the condition, as it offers a definitive method of diagnosis. Early detection through genetic testing can facilitate timely intervention and management strategies to improve quality of life for those affected by the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGFR3 Gene Hypochondroplasia Genetic Test

Test Name: FGFR3 Gene Hypochondroplasia Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGFR3 Gene Hypochondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR3 Gene Hypochondroplasia NGS Genetic DNA Test gene FGFR3

Test Details

The FGFR3 gene is a gene that codes for a protein called fibroblast growth factor receptor 3. Mutations in this gene have been associated with various skeletal disorders, including hypochondroplasia. Hypochondroplasia is a genetic disorder characterized by short stature and certain skeletal abnormalities. It is caused by specific mutations in the FGFR3 gene that result in the overactivity of the protein it codes for. This overactivity disrupts normal bone growth and leads to the characteristic features of the disorder.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of hypochondroplasia, NGS genetic testing can be used to identify mutations in the FGFR3 gene that are associated with the disorder. By identifying specific mutations in the FGFR3 gene through NGS genetic testing, healthcare professionals can confirm a diagnosis of hypochondroplasia and provide appropriate medical management and counseling for affected individuals and their families.

Test Name FGFR3 Gene Hypochondroplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGFR3 Gene Hypochondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR3 Gene Hypochondroplasia NGS Genetic DNA Test gene FGFR3
Test Details

The FGFR3 gene is a gene that codes for a protein called fibroblast growth factor receptor 3. Mutations in this gene have been associated with various skeletal disorders, including hypochondroplasia.

Hypochondroplasia is a genetic disorder characterized by short stature and certain skeletal abnormalities. It is caused by specific mutations in the FGFR3 gene that result in the overactivity of the protein it codes for. This overactivity disrupts normal bone growth and leads to the characteristic features of the disorder.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of hypochondroplasia, NGS genetic testing can be used to identify mutations in the FGFR3 gene that are associated with the disorder.

By identifying specific mutations in the FGFR3 gene through NGS genetic testing, healthcare professionals can confirm a diagnosis of hypochondroplasia and provide appropriate medical management and counseling for affected individuals and their families.